XML 18 R5.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Shareholders' Equity (Unaudited) - USD ($)
shares in Millions, $ in Millions
Total
Common Stock
Capital in Excess of Par Value
Accumulated Deficit
Treasury Stock
Noncontrolling Interests
Balance at beginning of period at Dec. 31, 2018 $ 1,557.0 $ 1.1 $ 2,588.7 $ (885.2) $ (427.9) $ 280.3
Balance at beginning of period (shares) at Dec. 31, 2018   98.9        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 345.5     291.1   54.4
Receipt of treasury stock (16.2)       (16.2)  
Receipt of treasury stock (shares)   (0.3)        
Dividends declared (81.5)   (81.5)      
Stock-based compensation 24.1   24.1      
Distributions declared (52.8)         (52.8)
Capital contributions from consolidated affiliates 20.0         20.0
Fair value adjustments to redeemable noncontrolling interests (118.9)   (118.9)      
Consolidation of Yuma Rehabilitation Hospital 25.0         25.0
Repurchases of common stock in open market (45.9)       (45.9)  
Repurchases of common stock in open market (shares)   (0.8)        
Other 15.0   5.4   (1.7) 11.3
Other (shares)   0.8        
Balance at end of period at Sep. 30, 2019 1,671.3 $ 1.1 2,417.8 (594.1) (491.7) 338.2
Balance at end of period (shares) at Sep. 30, 2019   98.6        
Balance at beginning of period at Jun. 30, 2019 1,583.8 $ 1.1 2,455.6 (691.7) (489.1) 307.9
Balance at beginning of period (shares) at Jun. 30, 2019   98.6        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 115.8     97.6   18.2
Receipt of treasury stock (0.1)       (0.1)  
Dividends declared (27.8)   (27.8)      
Stock-based compensation 7.8   7.8      
Distributions declared (20.2)         (20.2)
Capital contributions from consolidated affiliates 7.2         7.2
Fair value adjustments to redeemable noncontrolling interests (18.2)   (18.2)      
Consolidation of Yuma Rehabilitation Hospital 25.0         25.0
Repurchases of common stock in open market (2.1)       (2.1)  
Repurchases of common stock in open market (shares)   (0.1)        
Other 0.1   0.4   (0.4) 0.1
Other (shares)   0.1        
Balance at end of period at Sep. 30, 2019 1,671.3 $ 1.1 2,417.8 (594.1) (491.7) 338.2
Balance at end of period (shares) at Sep. 30, 2019   98.6        
Balance at beginning of period at Dec. 31, 2019 1,693.1 $ 1.1 2,369.9 (526.5) (492.3) 340.9
Balance at beginning of period (shares) at Dec. 31, 2019   98.6        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 251.4     198.2   53.2
Receipt of treasury stock (15.7)       (15.7)  
Receipt of treasury stock (shares)   (0.2)        
Dividends declared (83.9)   (83.9)      
Exchange of Holdings shares 46.3   27.1   19.2  
Exchange of Holdings shares (shares)   0.6        
Stock-based compensation 25.3   25.3      
Distributions declared (50.9)         (50.9)
Capital contributions from consolidated affiliates 32.5         32.5
Repurchases of common stock in open market (4.9)       (4.9)  
Repurchases of common stock in open market (shares)   (0.1)        
Other 2.5   4.7   (1.4) (0.8)
Other (shares)   0.5        
Balance at end of period at Sep. 30, 2020 1,895.7 $ 1.1 2,343.1 (328.3) (495.1) 374.9
Balance at end of period (shares) at Sep. 30, 2020   99.4        
Balance at beginning of period at Jun. 30, 2020 1,831.4 $ 1.1 2,362.4 (406.0) (494.7) 368.6
Balance at beginning of period (shares) at Jun. 30, 2020   99.4        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 97.9     77.7   20.2
Dividends declared (28.0)   (28.0)      
Stock-based compensation 8.3   8.3      
Distributions declared (21.8)         (21.8)
Capital contributions from consolidated affiliates 7.8         7.8
Other 0.1   0.4   (0.4) 0.1
Balance at end of period at Sep. 30, 2020 $ 1,895.7 $ 1.1 $ 2,343.1 $ (328.3) $ (495.1) $ 374.9
Balance at end of period (shares) at Sep. 30, 2020   99.4